Sophia M. Chung, M.D. Depts of Ophthalmology &

Slides:



Advertisements
Similar presentations
FERNE Brain Illness and Injury Course
Advertisements

Neurological Diseases Jerry Carley RN, MSN, MA, CNE
Heather D. Mannuel, MD, MBA March 12, 2008
FACULTY OF MEDICINE PHYSIOLOGY DEPARTMENT DR. NERMEN MADY DR. RAMEZ.
Myasthenia Gravis Dr. Belal M. Hijji, RN. PhD February 29, 2012.
Neuro-ophthalmic Consultants Northwest Ocular Myasthenia Gravis: Diagnostic Studies and Long Term Impact of Treatment Steven R. Hamilton, M.D. Neuro-ophthalmic.
Muscle weakness Index case Year 1 Michaelmas Term.
Guillain-Barré Syndrome, Myasthenia Gravis,
Terri Kueber, CRNA, MS. Explain the pathophysiology and classification of Myasthenia Gravis (MG) List the signs and symptoms and clinical manifestation.
Myasthenia gravis in the elderly Johan A. Aarli University of Bergen, Norway.
37 yo F Engineer PC: Double vision, fatigue, difficulty swallowing. HPC: - 3/52 of worsening diplopia, worse in afternoons - 3/7 of intermittent weakness.
Nuha Alkhawajah MD.   Disorders affecting the junction between the presynaptic nerve terminal and the postsynaptic muscle membrane  Pure motor syndromes.
Agents Used to Treat Musculoskeletal Health Alterations.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
Morning Report January 19 th, 2010 Jason Kidd.
 Myasthenia gravis is a chronic autoimmune neuromuscular disease that is characterized by different degrees of weakness of the skeletal muscles of the.
Ocular Myasthenia Gravis: Past, Present, and Future
Myasthenia Gravis Shirley H. Wray, M.D., Ph.D.
1 Review of Musculoskeletal System Chapter Muscle Skeletal muscle > 600 muscles in body Fascia –Epimysium – forms tendons at ends –Perimysium –
Myasthenia Gravis Blaine Suing November 21 st 2007.
Graves’ and Thyroid Disease: The Journey
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
GENERAL THORACIC SURGERY CHAPTER 168
Public Health – Dresden Medical School Complementary care seeking behavior in patients with Myasthenia gravis J. Klewer 1, L. Wondzinski 1, A. Friedrich.
Myasthenia Gravis Erin O’Ferrall Colin Chalk March 11, 2009.
Myasthenia Gravis 重症肌无力(MG)
Myasthenia Gravis.  Describe myasthenia gravis  Signs and Symptoms of the disease  Describe the treatments available Purpose and Objectives.
Disorders of neuromuscular junction: Prepared by: Dr. Sarwer Jamal Bajalan M.B.Ch.B, F.I.B.M.S(Neurology)
MUSCULAR DYSTROPHIES Characteristics: 1-slowly progressive 2-myopathy(EMG-clinic-patholo 3-no metabolic storage 4-symptoms are due to weakne.
MYASTHENIA GRAVIS (MG)
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A 64 y/o Woman with Dyspnea Pamela Ryan MD February 14, 2007.
Thymoma a primary tumor of the thymus gland Bradley J. Phillips, MD.
Myasthenia Gravis Victor Politi,M.D.
MYASTHENIA GRAVIS ANESTHESIOLOGY Jasdeep Dhaliwal Clinical Rotation.
Pathophysiology, Diagnosis and Medical Management of Myasthenia Gravis
Medical and Surgical Management of MG Brian A. Crum, MD Department of Neurology Mayo Clinic Rochester, MN MGFA National Meeting, St. Louis May, 2010.
By Dr. Zahoor 1. Question 1: 1.What do you observe in this male patient? 2.Give one cause. 2.
Myasthenia Gravis.
Neuromuscular Signs and Symptoms: Muscle stiffness, ptosis, axial muscle weakness 1 W. David Arnold, MD AAPMR 2015 Disclosure: I receive funding through.
Disorders of the Neuromuscular Junction
Myasthenia Gravis.
Neurology Chapter of IAP
MYASTHENIA GRAVIS Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin.
Myasthenia gravis Treatment Recommendations Treatment Anticholinesterases Immunosuppressants Thymectomy Plasma exchange and IVIG.
NEUROPATHY Subsection B3 Francisco – Go, Kerby + Laxamana September 16, 2009.
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Relapsing Polychondritis Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
MYASTHENIA GRAVIS “FROM WEAKNESS SHALL COME STRENGTH”. BY PATTI HAMILTON.
Kaitlyn Bradshaw. Is a rapid pain under any voluntary muscle DESCRIPTION.
Assessment and Treatments  History: weakness caused by any precipitating factors ( i.e. infection, emotional upset)  Time of weakness: after repeated.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
Nursing management of Myasthenia Gravis
Myasthenia Gravis.
Myasthenia Gravis.
Jennifer Vilarino Period: 5
Neuromuscular disorders
Myasthenia Gravis.
Neuromuscular junction
Prednisone for MG Richard J. Barohn, MD Gary Gronseth, MD
Dysthyroid eye disease
Myasthenia Gravis.
Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin
Myasthenia gravis By: Nikki Young.
“Grave Muscle Weakness”
Thymectomy for Myasthenia Gravis? YES!
Figure 2 Clinical course and response to therapy in 6 Australian patients with HMGCR antibodies The clinical course, creatine kinase (CK) levels, Medical.
Brett Mueller, D.O., Ph.D. December 15, 2017
Presentation transcript:

Eye Findings in Myasthenia Gravis: Diagnosis, Evaluation, and Treatment Sophia M. Chung, M.D. Depts of Ophthalmology & Neurology and Psychiatry Saint Louis University School of Medicine

Ocular Myasthenia Gravis >90% patients w/MG have eye finding Ptosis (droopy lid) Diplopia (double vision) 50% patients’ initial presentation of MG Most convert to generalized MG Within 2 years

Ocular Myasthenia Gravis Pure ocular disease occurs in 20% MG Later age Men > women

Generalized Myasthenia (Grob et al. ‘81)

Ocular Myasthenia (Grob et al. ‘81)

Ocular Myasthenia Gravis 24 yo man complains of droopiness of left upper lid-variable throughout the day

Ocular Myasthenia Gravis Ptosis Isolation Company of double vision Variable Often asymmetric Fatigable Worsens later in the day

Ocular Myasthenia Gravis

Ocular Myasthenia Gravis Patient photos

Ocular Myasthenia Gravis Ptosis (droopy eyelid) Cogan’s lid twitch Patient asked to look up after looking down Eyelid briefly over-elevated and appears to be waving

Ocular Myasthenia Gravis Video ptosis from MG

Myasthenia Gravis Double vision Variable May involve: One eye muscle Multiple eye muscles All eye muscles

Ocular Myasthenia Gravis Patient photos

Ocular Myasthenia Gravis Diagnosis Sleep test Ice test www.globalspine.net/best_position_sleeping.html www.smartertravel.com/travel-advice

Ocular Myasthenia Gravis Before ice test After ice test

Ocular Myasthenia Gravis Weakness of eyelid muscles Nearly always present www.yorku.ca/earmstro/journey/images/facial.gif

Ocular Myasthenia Gravis Diagnosis: anti-acetylcholine receptor Ab Present in 80-90% generalized MG Present in 50% ocular MG Level has no correlation with disease activity

Ocular Myasthenia Gravis Thyroid function tests 20% MG patients has concurrent thyroid disease Anti-nuclear antibody Erythrocyte sedimentation rate

Ocular Myasthenia Gravis Tensilon test Test dose Bolus Response within 30 sec Duration 2-5 minutes Look for change

Ocular Myasthenia Gravis Patient photos

Ocular Myasthenia Gravis Repetitive stimulation test Positive 20-30% ocular MG Single fiber EMG Eyelid muscles or forehead 85-100% sensitivity www.eorthopod.com/images/ContentImages/spine

Ocular Myasthenia Gravis Chest CT Thymomas present in 15% all MG patients Considered rare-uncommon in ocular MG Presence warrants surgery

Myasthenia Gravis CT chest Thymoma 10-15% of MG (of thymomas, 50% have MG) >age 30, males Thymus hyperplasia 60-80% younger age, females Anti-Ach Rec Ab +95-100% of the time w/thymoma

Ocular Myasthenia Gravis No randomized clinical trials for pure ocular MG Treatment based on clinical experience, retrospective trials

Ocular Myasthenia Gravis Treatment Withdraw medications that might exacerbate MG Long list: cardiac drugs, antibiotics, anti-epileptics, psychiatric drugs Most common: aminoglycosides and beta-blockers

Ocular Myasthenia Gravis Pyridostigmine (Mestinon) Less effective in pure ocular MG 50% patients respond Ptosis responds better than diplopia Side effects: gastrointestinal Contraindications: bradycardia, reactive airway disease, BPH

Ocular Myasthenia Gravis Corticosteroids Start low (5-10mg) and increase slowly until symptoms improve Maintain resolution Slow taper Recurrence common despite slow taper Improvement of ptosis & diplopia 72-96% patients

Ocular Myasthenia Gravis Corticosteroids Side effects Mood swings -Cataract Sleep disorders -GERD Hyperglycemia -Osteoporosis Weight gain -Hypertension

Ocular Myasthenia Gravis Azathioprine Mycophenolate mofetil Cyclosporine A Tacrolimus Cyclophosphamide Rituximab Etanercept

Myasthenia Gravis Plasmapharesis (respiratory failure) Human Immunoglobulin Thymectomy Referral to Neurologist

Ocular Myasthenia Gravis Patient photos

Myasthenia Gravis: Thymectomy Data for generalized MG helpful early in disease Promotes long term clinical improvement under the age of 50 Unclear role with pure ocular MG Always indicated with the presence of thymoma 50% chance of malignancy

Patient photos

Ocular Myasthenia Gravis Conclusions >90% patients w/MG have eye finding Ptosis and diplopia 50% patients’ initial presentation of MG Most convert to generalized MG

Ocular Myasthenia Gravis Conclusions 20% MG is purely ocular Diagnosis often more challenging Treatment usually requires 2 or more drugs